In the management of familial hypercholesterolaemia, which of the following is administered by subcutaneous injection?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

In the management of familial hypercholesterolaemia, which of the following is administered by subcutaneous injection?

Explanation:
For some familial hypercholesterolaemia therapies, especially larger molecule drugs like PCSK9 inhibitors, the route of administration is subcutaneous injection. These agents are designed for injection under the skin to achieve steady, convenient dosing intervals, rather than being taken as pills or given by inhalation or IV. Hence, the option describing the administration method itself matches the question. Oral tablets are used for statins and ezetimibe, inhalation isn’t used for lipid-lowering therapy, and intravenous infusion is used with other types of drugs but not the common FH monoclonal antibodies.

For some familial hypercholesterolaemia therapies, especially larger molecule drugs like PCSK9 inhibitors, the route of administration is subcutaneous injection. These agents are designed for injection under the skin to achieve steady, convenient dosing intervals, rather than being taken as pills or given by inhalation or IV. Hence, the option describing the administration method itself matches the question. Oral tablets are used for statins and ezetimibe, inhalation isn’t used for lipid-lowering therapy, and intravenous infusion is used with other types of drugs but not the common FH monoclonal antibodies.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy